Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor, Adult × Aspirin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 8 Polycythemia Vera 5 Prostatic Neoplasms 4 Neoplasms 4 Multiple Myeloma 4 Colonic Neoplasms 4 Cardiovascular Diseases 4 Venous Thromboembolism 3 Precancerous Conditions 3 Ovarian Neoplasms 3 Neoplasms, Plasma Cell 3 Myeloproliferative Disorders 3 Melanoma 3 Esophageal Neoplasms 3 Barrett Esophagus 3 Thrombosis 2 Thromboembolism 2 Thrombocythemia, Essential 2 Stomach Neoplasms 2 Rectal Neoplasms 2 Head and Neck Neoplasms 2 Adenomatous Polyps 2 Vascular Diseases 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Breast Neoplasms 1 Tobacco Use Disorder 1 Stroke 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor, Adult 1

Interventions

pembrolizumab 2 Ipilimumab 2 Blood Specimen Collection 2 spartalizumab 1 necitumumab 1 leronlimab 1 Watchful Waiting 1 Tomography, X-Ray Computed 1 Therapeutics 1 Surveys and Questionnaires 1 Radiotherapy 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1 Jupiter 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 GAT 1 Fluorodeoxyglucose F18 1 FCN-437c 1 EBI-005 1 Cyclophosphamide 1 Cetuximab 1 Celecoxib 1 CS-1003 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03728179 2024-02-20

RACIN

Centre Hospitalier Universitaire Vaudois

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡